General Information of the Compound
| Compound ID |
CP0569150
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[[4-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1-bicyclo[2.2.2]octanyl]methyl]-N-[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)phenyl]-1-methylpiperidine-4-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H40N6O3
|
||||||||||||||||||
| Molecular Weight |
556.711
|
||||||||||||||||||
| Canonical SMILES |
CN1CCC(CC1)C(=O)N(CC12CCC(CC1)(CC2)c1nc(no1)C1CC1)c1cccc(c1)-c1nc(no1)C1CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H40N6O3/c1-37-17-9-23(10-18-37)29(39)38(25-4-2-3-24(19-25)28-33-26(35-40-28)21-5-6-21)20-31-11-14-32(15-12-31,16-13-31)30-34-27(36-41-30)22-7-8-22/h2-4,19,21-23H,5-18,20H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
KUTWRPJPBIBXQX-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound